We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.61B
1-Year Est. Return
28.28%
This Fund
S&P 500
This Quarter
Est. Return
+4.62%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.81B
AUM Growth
+$240M
(+15%)
Cap. Flow
+$208M
Cap. Flow
% of AUM
11.48%
Top 10 Holdings %
Top 10 Hldgs %
3.88%
Holding
2,105
New
481
Increased
671
Reduced
539
Closed
400
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$9.12M |
| 2 |
Visa
V
|
+$8.75M |
| 3 |
Motorola Solutions
MSI
|
+$7.37M |
| 4 |
Edwards Lifesciences
EW
|
+$7.3M |
| 5 |
CTXS
Citrix Systems Inc
CTXS
|
+$4.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$6.1M |
| 2 |
Bausch Health
BHC
|
+$5.94M |
| 3 |
Deere & Co
DE
|
+$5.72M |
| 4 |
Constellation Brands
STZ
|
+$4.59M |
| 5 |
Qualcomm
QCOM
|
+$4.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.07% |
| 2 | Industrials | 13.48% |
| 3 | Consumer Discretionary | 12.62% |
| 4 | Technology | 11.4% |
| 5 | Financials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Dawson Geophysical
DWSN
$143M
| $129K | 0.01% |
+16,590
| New | +$96.5K |
|
|
SIOX
1652
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $128K | 0.01% |
+1,250
| New | +$125K |
|
1653
Calix
CALX
$2.22B
| $125K | 0.01% |
18,068
+5,700
| +46% | +$39K |
|
|
CO
1654
DELISTED
Global Cord Blood Corporation
CO
| $118K | 0.01% |
20,577
-16,480
| -44% | -$100K |
|
1655
Exelixis
EXEL
$14.1B
| $117K | 0.01% |
+14,982
| New | +$86.3K |
|
1656
Iridium Communications
IRDM
$5.05B
| $117K | 0.01% |
13,200
-12,100
| -48% | -$99.4K |
|
1657
McEwen Inc
MUX
$1.06B
| $116K | 0.01% |
+3,007
| New | +$79.5K |
|
1658
Intrepid Potash
IPI
$474M
| $114K | 0.01% |
+7,910
| New | +$99.9K |
|
1659
Ultralife
ULBI
$85.9M
| $113K | 0.01% |
22,500
+300
| +1% | +$1.42K |
|
|
FENX
1660
DELISTED
Fenix Parts, Inc.
FENX
| $112K | 0.01% |
28,505
-173,785
| -86% | -$735K |
|
|
CCR
1661
DELISTED
CONSOL Coal Resources LP
CCR
| $105K | 0.01% |
11,294
-70,307
| -86% | -$593K |
|
1662
Accuray
ARAY
$33.9M
| $104K | 0.01% |
+20,105
| New | +$110K |
|
1663
VirnetX Holding Corp
VHC
$54.7M
| $104K | 0.01% |
+1,305
| New | +$120K |
|
|
CDI
1664
DELISTED
CDI Corp.
CDI
| $104K | 0.01% |
17,120
-92,329
| -84% | -$592K |
|
|
KZ
1665
DELISTED
KongZhong Corporation
KZ
| $104K | 0.01% |
20,600
-49,868
| -71% | -$308K |
|
|
PR
1666
Permian Resources
PR
$17.6B
| $101K | 0.01% |
+10,101
| New | +$101K |
|
|
ATYR
1667
aTyr Pharma
ATYR
$47.1M
| $101K | 0.01% |
+2,607
| New | +$121K |
|
1668
Old Second Bancorp
OSBC
$1.29B
| $100K | 0.01% |
14,600
+2,100
| +17% | +$14.9K |
|
1669
CarParts.com
PRTS
$42.4M
| $100K | 0.01% |
+2,540
| New | +$88K |
|
1670
Lakeland Industries
LAKE
$109M
| $99K | 0.01% |
+11,370
| New | +$107K |
|
|
PES
1671
DELISTED
Pioneer Energy Services Corp.
PES
| $99K | 0.01% |
21,580
-222,500
| -91% | -$732K |
|
|
ARTX
1672
DELISTED
Arotech Corporation
ARTX
| $98K | 0.01% |
34,800
-12,900
| -27% | -$39.2K |
|
|
IRG
1673
DELISTED
Ignite Restaurant Group, Inc.
IRG
| $96K | 0.01% |
61,338
-79,032
| -56% | -$205K |
|
1674
Allot
ALLT
$367M
| $94K | 0.01% |
+19,100
| New | +$95.6K |
|
1675
Unisys
UIS
$230M
| $93K | 0.01% |
+12,781
| New | +$97.9K |
|
Similar funds
ACB
SCI
SCM
BW
TLFA
HH
KCM
PRA
GSA Capital Partners's Q2 2016 Portfolio in Review
As of Q2 2016, GSA Capital Partners held 2,105 positions worth $1.81B, up 15% from $1.57B the previous quarter. Its ten largest holdings account for 3.9% of the portfolio.
GSA Capital Partners deployed $208M of net new capital in Q2 2016, opening 481 new positions and adding to 671 existing holdings. Its largest new stake was Mastercard: 95,471 shares worth $8.41M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Bausch Health, an estimated $5.94M trimmed.
- GSA Capital Partners's largest Q2 2016 buy was Mastercard: 95,471 shares worth $8.41M.
- GSA Capital Partners added most to Motorola Solutions in Q2 2016, an estimated $7.37M increase.
- GSA Capital Partners's biggest Q2 2016 reduction was Bausch Health, cutting an estimated $5.94M.
- GSA Capital Partners fully exited Allergan plc in Q2 2016, selling an estimated $6.1M.
- GSA Capital Partners's ten largest holdings make up 3.9% of its $1.81B portfolio in Q2 2016.
- GSA Capital Partners opened 481 new positions and closed 400 in Q2 2016.
- GSA Capital Partners's portfolio value rose 15% quarter-over-quarter to $1.81B.
Based on GSA Capital Partners's 13F filing for Q2 2016, filed 4 Aug 2016.